These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 37907491)

  • 41. Clinical Features and the Validation of the Brighton Criteria in Guillain-Barré Syndrome: Retrospective Analysis of 72 Hospitalized Patients in Three Years.
    Zeng Y; Liu Y; Xie Y; Liang J; Xiao Z; Lu Z
    Eur Neurol; 2019; 81(5-6):231-238. PubMed ID: 31574518
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characteristics of Guillain-Barré syndrome in a Lebanese tertiary care center.
    Ismail H; Malek E; Saroufim L; Salameh J
    Neuromuscul Disord; 2021 Aug; 31(8):765-768. PubMed ID: 34238653
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognosis of patients with Guillain-Barré syndrome requiring mechanical ventilation.
    Netto AB; Taly AB; Kulkarni GB; Uma Maheshwara Rao GS; Rao S
    Neurol India; 2011; 59(5):707-11. PubMed ID: 22019655
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors of Mechanical Ventilation in Guillain-Barré Syndrome with Axonal Subtypes.
    Michel-Chávez A; Chiquete E; Gulías-Herrero A; Carrillo-Pérez DL; Olivas-Martínez A; Macías-Gallardo J; Aceves-Buendía JJ; Ruiz-Ruiz E; Bliskunova T; Portillo-Valle J; Cobilt-Catana R; Ortiz-Quezada JA; Durán-Coyote S; Rodríguez-Perea E; Aguilar-Salas E; Cantú-Brito C; García-Ramos G; Estañol B
    Can J Neurol Sci; 2023 Mar; 50(2):221-227. PubMed ID: 35189990
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of intravenous immunoglobulin and plasmapheresis on nerve conduction parameters compared to the natural course of Guillain-Barré syndrome.
    Kalita J; Mahajan R; Kumar M
    J Clin Neurosci; 2024 Jul; 125():76-82. PubMed ID: 38759351
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical Features of Post-Vaccination Guillain-Barré Syndrome (GBS) in Korea.
    Park YS; Lee KJ; Kim SW; Kim KM; Suh BC
    J Korean Med Sci; 2017 Jul; 32(7):1154-1159. PubMed ID: 28581273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dysautonomia in Guillain-Barré Syndrome: Prevalence, Clinical Spectrum, and Outcomes.
    Chakraborty T; Kramer CL; Wijdicks EFM; Rabinstein AA
    Neurocrit Care; 2020 Feb; 32(1):113-120. PubMed ID: 31297663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Guillain-Barre syndrome: Demographics, clinical profile & seasonal variation in a tertiary care centre of central India.
    Shrivastava M; Nehal S; Seema N
    Indian J Med Res; 2017 Feb; 145(2):203-208. PubMed ID: 28639596
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IgG Fc N-glycosylation in Guillain-Barré syndrome treated with immunoglobulins.
    Fokkink WJ; Selman MH; Dortland JR; Durmuş B; Kuitwaard K; Huizinga R; van Rijs W; Tio-Gillen AP; van Doorn PA; Deelder AM; Wuhrer M; Jacobs BC
    J Proteome Res; 2014 Mar; 13(3):1722-30. PubMed ID: 24533874
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Guillain-Barré syndrome in Ethiopian patients.
    Melaku Z; Zenebe G; Bekele A
    Ethiop Med J; 2005 Jan; 43(1):21-6. PubMed ID: 16370526
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment related fluctuation and response to intravenous immunoglobulin therapy in post COVID-19 Guillain-Barre syndrome.
    Gupta S; Chandra A; Ray BK; Pandit A
    Diabetes Metab Syndr; 2021; 15(5):102246. PubMed ID: 34416468
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Rare case of recurrent Guillain-Barré syndrome without albuminocytological dissociation.
    Yelam A; Nagarajan E; Govindarajan R; Bollu PC
    BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30333201
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnosis of Guillain-Barré syndrome in children and validation of the Brighton criteria.
    Roodbol J; de Wit MY; van den Berg B; Kahlmann V; Drenthen J; Catsman-Berrevoets CE; Jacobs BC
    J Neurol; 2017 May; 264(5):856-861. PubMed ID: 28251358
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Guillain-Barre syndrome in North Indian children: Clinical and serial electrophysiological features.
    Yadav S; Jain P; Sharma S; Kumar V; Aneja S
    Neurol India; 2019; 67(3):724-727. PubMed ID: 31347543
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinically diagnosed Guillain-Barre syndrome in Ile-Ife, Nigeria.
    Sunmonu TA; Komolafe MA; Adewuya A; Olugbodi AA
    West Afr J Med; 2008 Jul; 27(3):167-70. PubMed ID: 19256323
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical and electrophysiologic features of childhood Guillain-Barré syndrome in Northeast China.
    Ye YQ; Wang KR; Sun L; Wang Z
    J Formos Med Assoc; 2014 Sep; 113(9):634-9. PubMed ID: 25103077
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical characteristics of children with Guillain-Barré syndrome and factors associated with disease severity.
    Luo HY; Li XJ; Cheng M; Wang J; Xie LL; Yao ZX; Jiang L
    J Clin Neurosci; 2021 Oct; 92():120-125. PubMed ID: 34509238
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical variants of Guillain-Barre syndrome: some aspects of differential diagnosis.
    Dididze MN
    Georgian Med News; 2009 Jan; (166):48-51. PubMed ID: 19202218
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Study of Sensory Nerve Conduction in Pre- and Post-immunoglobulin Treatment of Guillain-Barré Syndrome.
    A P; Shende V; Pawar S
    Cureus; 2024 Jan; 16(1):e51673. PubMed ID: 38313916
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic Implications of Early Albuminocytological Dissociation in Guillain-Barré Syndrome.
    Vargas-Cañas ES; Galnares-Olalde JA; León-Velasco F; García-Grimshaw M; Gutiérrez A; López-Hernández JC
    Can J Neurol Sci; 2023 Sep; 50(5):745-750. PubMed ID: 35979659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.